Home > Insider Trading > Filing (0001144204-16-120578)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1012477	Flamel Technologies Sa	FLML	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1144178	S Michael Anderson	33, Avenue Du Docteur Georges Levy Venissieux I0 69200	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Adss	Acquisiton	2016-08-22	5,000	$14.30	189,250	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Adss	Stock Option (right to buy)	$6.93	2022-03-08	275,000	275,000	Direct
Adss	Stock Option (right to buy)	$4.07	2023-02-01	80,500	80,500	Direct
Adss	Stock Option (right to buy)	$16.30	2024-12-11	200,000	200,000	Direct
Adss	Stock Option (right to buy)	$14.35	2025-12-10	200,000	200,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-03-08	275,000	275,000	Direct
2023-02-01	80,500	80,500	Direct
2024-12-11	200,000	200,000	Direct
2025-12-10	200,000	200,000	Direct

Footnotes

The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value 0.122 Euros per share, of the issuer; ADSs are represented by American Depositary Receipts. The securities acquired as reported in this statement represent the grant of ADSs under the issuer's "Free Share" award program; no purchase price was applicable to such grant. See footnote (2) for details as to the dates such ADSs will be issued to the reporting person.
Includes (a) 50,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/11/2014, all of which will be issued to the reporting person on the fourth anniversary of the grant date, provided that the reporting person continues to be employed by the issuer or an affiliate thereof on the second anniversary of the grant date; and (b) 50,000 restricted ADSs granted under the issuer's "Free Share" award program on 8/10/2016, all of which will be issued to the reporting person on the second anniversary of the grant date.
Options became exercisable in four equal amounts over the first four anniversaries after the 03/08/2012 grant date.
Options become exercisable as to 20,125 ADSs on each of the first four anniversaries after the 02/01/2013 grant date.
Options become exercisable as to 50,000 ADSs on each of the first four anniversaries after the 12/11/2014 grant date.
Options become exercisable as to 50,000 ADSs on each of the first four anniversaries after the 12/10/2015 grant date.